Showing results (1191-1200 of 1,250) with videos related to

Sort By:
Pageof 125
Cerebrovascular Diseases (Basel, Switzerland)|December 1, 2022
Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen OvaleKeith Zhi Xian Toh, Ming Yi Koh, Jamie S Y Ho, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2026
Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials NetworkN Kovalchuk, E Simiele, M LaRiviere, et al.
The New England Journal of Medicine|June 22, 2017
Cluster-Randomized, Crossover Trial of Head Positioning in Acute StrokeCraig S Anderson, Hisatomi Arima, Pablo Lavados, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 13, 2010
Three phenotypes of obstructive lung disease in the elderlyK-W Jo, S W Ra, E J Chae, et al.
Physical Review Letters|May 29, 2026
Search for Dark Particles in K_{L}^{0}→γX at the KOTO ExperimentT Wu, Y C Tung, Y B Hsiung, et al.
Science (New York, N.Y.)|January 6, 2018
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivaxJakub Gruszczyk, Usheer Kanjee, Li-Jin Chan, et al.
Pediatric Nephrology (Berlin, Germany)|January 14, 2026
APOL1 kidney risk variants and outcomes in children with congenital anomalies of the kidney and urinary tractLisanne M Vendrig, Juntao Ke, Michael W T Tanck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆S H Park, D H Lim, T S Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS T Kim, K C Banks, E Pectasides, et al.
Cell Genomics|February 13, 2023
Retinal ganglion cell-specific genetic regulation in primary open-angle glaucomaMaciej Daniszewski, Anne Senabouth, Helena H Liang, et al.
Pageof 125